A Retrospective Study of the Safety and Immunogenicity of MVC-COV1901 Vaccine for People Living with HIV

被引：4

作者：

Cheng, Shu-Hsing ^{[1
,2
]}

Lien, Chia En ^{[3
,4
]}

Hsieh, Szu-Min ^{[5
,6
]}

Cheng, Chien-Yu ^{[1
,4
]}

Liu, Wang-Da ^{[5
,7
]}

Lo, Ching-Lung ^{[8
,9
]}

Ko, Wen-Chien ^{[8
,9
]}

Chen, Yen-Hsu ^{[10
,11
,12
]}

Huang, Ching-Tai ^{[13
,14
]}

Chang, Hsiao-Ting ^{[15
,16
]}

Hwang, Shinn-Jang ^{[15
,16
]}

Wang, Ning-Chi ^{[17
]}

Liu, Ming-Che ^{[18
,19
]}

Lee, Yu-Lin ^{[20
,21
]}

Tai, I-Chen ^{[3
]}

Estrada, Josue Antonio Garcia ^{[3
]}

Lin, Tzou-Yien ^{[14
,22
]}

Lee, Wen-Sen ^{[23
,24
]}

机构：

[1] Taoyuan Gen Hosp, Dept Infect Dis, Minist Hlth & Welf, Taoyuan 330, Taiwan

[2] Taipei Med Univ, Sch Publ Hlth, Taipei 110, Taiwan

[3] Medigen Vaccine Biol, Taipei 114, Taiwan

[4] Natl Yang Ming Chiao Tung Univ, Inst Publ Hlth, Coll Med, Taipei 112, Taiwan

[5] Natl Taiwan Univ Hosp, Dept Internal Med, Div Infect Dis, Taipei 100, Taiwan

[6] Natl Taiwan Univ, Coll Med, Taipei 106, Taiwan

[7] Natl Taiwan Univ, Dept Med, Canc Ctr, Taipei 100, Taiwan

[8] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 704, Taiwan

[9] Natl Cheng Kung Univ, Coll Med, Dept Med, Tainan 701, Taiwan

[10] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung 807, Taiwan

[11] Kaohsiung Med Univ, Grad Inst Med, Sepsis Res Ctr, Sch Med, Kaohsiung 807, Taiwan

[12] Kaohsiung Med Univ, Ctr Trop Med & Infect Dis, Kaohsiung 807, Taiwan

[13] Chang Gung Mem Hosp, Dept Infect Dis, Taoyuan 333, Taiwan

[14] Chang Gung Univ, Coll Med, Taoyuan 333, Taiwan

[15] Taipei Vet Gen Hosp, Dept Family Med, Taipei 112, Taiwan

[16] Natl Yang Ming Chiao Tung Univ, Sch Med, Taipei 112, Taiwan

[17] Triserv Gen Hosp, Taipei 114, Taiwan

[18] Taipei Med Univ Hosp, Clin Res Ctr, Taipei 110, Taiwan

[19] Taipei Med Univ, Coll Oral Med, Sch Dent Technol, Taipei 110, Taiwan

[20] Changhua Christian Hosp, Dept Internal Med, Changhua 500, Taiwan

[21] Natl Chung Hsing Univ, Program Med Biotechnol, Taichung 402, Taiwan

[22] Chang Gung Mem Hosp, Dept Paediat, Taoyuan 333, Taiwan

[23] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Infect Dis, Taipei 116, Taiwan

[24] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei 110, Taiwan

来源：

VACCINES | 2023年 / 11卷 / 01期

关键词：

COVID-19; vaccine; CpG; 1018; S-2P protein; HIV; CD4; CD8; ratio; immunogenicity; HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-B VACCINATION; T-CELL DIFFERENTIATION; ANTIBODY-RESPONSE; COVID-19; VACCINE; MESSENGER-RNA; SARS-COV-2; INFECTION; NUMBER; ADULTS;

D O I：

10.3390/vaccines11010018

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Background: This study aimed to assess the safety and immunogenicity of MVC-COV1901, a recombinant COVID-19 protein vaccine, containing S-2P protein adjuvanted with CpG 1018 and aluminum hydroxide, for people living with HIV (PWH). Methods: A total of 57 PWH of >= 20 years of age who are on stable antiretroviral therapy were compared with 882 HIV-negative participants. Participants received two doses of MVC-COV1901 28 days apart. Results: No vaccine-related serious adverse events (SAEs) were recorded. Seroconversion rates (SCRs) of 100% and 99.8% were achieved in PWH and comparators, respectively, 28 days after the second dose. After adjusting for sex, age, BMI category, and comorbidity, the adjusted GMT ratio of comparator/PWH was 3.2 (95% CI 2.5-4). A higher CD4/CD8 ratio was associated with a higher GMT (R = 0.27, p = 0.039). MVC-COV1901 has shown robust safety but elicited weaker immune responses in PWH. Conclusions: Further investigations may be needed to determine whether PWH require distinct immunization strategies with improved immunogenicity. The main study is registered at ClinicalTrials.gov (NCT04695652).

引用

页数：14

共 50 条

[41] Humoral immunogenicity of mRNA SARS-COV-2 vaccines among people living with HIV
Robles, A. G.
Nomah, D. K.
Bruguera, A.
Tiraboschi, J. M.
Benet, S.
Garcia-Perez, J.
Jimenez, P.
Sanchez-Palomino, S.
Suanzes, P.
Garcia-Gazalla, M.
Homar, F.
Mothe, B.
Reyes-Uruena, J.
Buzon, M. J.
Miro, J. M.
HIV MEDICINE, 2023, 24 : 295 - 296
[42] An Immunobridging Study to Evaluate the Neutralizing Antibody Titer in Adults Immunized with Two Doses of Either ChAdOx1-nCov-19 (AstraZeneca) or MVC-COV1901
Estrada, Josue Antonio
Cheng, Chien-Yu
Ku, Shin-Yen
Hu, Hui-Chun
Yeh, Hsiu-Wen
Lin, Yi-Chun
Chen, Cheng-Pin
Cheng, Shu-Hsing
Janssen, Robert
Lin, I-Feng
VACCINES, 2022, 10 (05)
[43] Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study
Hensley, Kathryn S.
Jongkees, Marlou J.
Geers, Daryl
GeurtsvanKessel, Corine H.
Mueller, Yvonne M.
Dalm, Virgil A. S. H.
Papageorgiou, Grigorios
Steggink, Hanka
Gorska, Alicja
Bogers, Susanne
den Hollander, Jan G.
Bierman, Wouter F. W.
Gelinck, Luc B. S.
Schippers, Emile F.
Ammerlaan, Heidi S. M.
van der Valk, Marc
van Vonderen, Marit G. A.
Delsing, Corine E.
Gisolf, Elisabeth H.
Bruns, Anke H. W.
Lauw, Fanny N.
Berrevoets, Marvin A. H.
Sigaloff, Kim C. E.
Soetekouw, Robert
Branger, Judith
de Mast, Quirijn
Lammers, Adriana J. J.
Lowe, Selwyn H.
de Vries, Rory D.
Katsikis, Peter D.
Rijnders, Bart J. A.
Brinkman, Kees
Roukens, Anna H. E.
Rokx, Casper
PLOS MEDICINE, 2022, 19 (10)
[44] Safety and immunogenicity of the nonavalent human papillomavirus (nHPV) vaccine in Spanish Women Living with HIV (WLHIV)
Hidalgo-Tenorio, C.
Gomez-Ronquillo, P.
Moya, R.
Pasquau, J.
Omar Mohamed, M.
Sam Pedro, A.
Vinuesa, D.
Lopez-Hidalgo, J.
Lopez Ruz, M. A.
Sequera-Arquelladas, S.
Garcia-Vallecillos, C.
HIV MEDICINE, 2021, 22 : 260 - 260
[45] Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1
Levy, Itzchak
Wieder-Finesod, Anat
Litchevsky, Vladyslav
Biber, Asaf
Indenbaum, Victoria
Olmer, Liraz
Huppert, Amit
Mor, Orna
Goldstein, May
Levin, Einav Gal
Hod, Tammy
Cohen, Carmit
Lustig, Yaniv
Rahav, Galia
CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (12) : 1851 - 1855
[46] AIDS Malignancy Consortium 054: Safety and Immunogenicity of the Quadrivalent Vaccine in Indian Women Living With HIV
Palefsky, Joel M.
Poongulali, Selvamuthu
Lensing, Shelly
Lee, Jeannette
Da Costa, Maria
Chein, Aung
Beulah, Faith
Murugavel, K. G.
Kumarasamy, Nagalingeswaran
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2021, 87 (02) : 875 - 881
[47] Immunogenicity and safety of SARS-CoV-2 recombinant spike protein vaccine in South African people living with and without HIV-1 infection: A phase 2 randomised trial
Bennett, Chijioke
Hoosain, Zaheer
Koen, Anthonet
Lalloo, Umesh
Louw, Cheryl
Maluleke, Vongane
Patel, Faeezah
Benade, Gabriella
Venter, Esme Louise
Galbiati, Shirley
Shinde, Vivek
Madhi, Shabir A.
JOURNAL OF INFECTION, 2024, 89 (06)
[48] COVID-19 vaccine immunogenicity in people with HIV
Costiniuk, Cecilia T.
Singer, Joel
Lee, Terry
Langlois, Marc-Andre
Arnold, Corey
Galipeau, Yannick
Needham, Judy
Kulic, Iva
Jenabian, Mohammad-Ali
Burchell, Ann N.
Shamji, Hasina
Chambers, Catharine
Walmsley, Sharon
Ostrowski, Mario
Kovacs, Colin
Tan, Darrell H. S.
Harris, Marianne
Hull, Mark
Brumme, Zabrina L.
Lapointe, Hope R.
Brockman, Mark A.
Margolese, Shari
Mandarino, Enrico
Samarani, Suzanne
Vulesevic, Branka
Lebouche, Bertrand
Angel, Jonathan B.
Routy, Jean-Pierre
Cooper, Curtis L.
Anis, Aslam H.
AIDS, 2023, 37 (01) : F1 - F10
[49] Immunogenicity and reactogenicity of yellow fever vaccine in people with HIV
Motta, Edwiges
Camacho, Luiz Antonio B.
Cunha, Marcelo
de Filippis, Ana Maria Bispo
Lima, Sheila M. B.
Costa, Marcellus
Pedro, Luciana
Cardoso, Sandra W.
Cortes, Fernanda Heloise
Giacoia-Gripp, Carmem B. W.
Morata, Michelle
Nazer, Sandro
Moreira, Ronaldo Ismerio
de Oliveira Souza, Marta Cristina
Mendes, Ygara S.
Souza Azevedo, Adriana de
dos Santos Alvez, Nathalia
Grinsztejn, Beatriz
Coelho, Lara E.
AIDS, 2023, 37 (15) : 2319 - 2329
[50] Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine
Underwood, Eddie
Dunkle, Lisa M.
Madhi, Shabir A.
Gay, Cynthia L.
Heath, Paul T.
Kotloff, Karen L.
Smith, Katherine
Chau, Gordon
Galbiati, Shirley
McGarry, Alice
Woo, Wayne
Cho, Iksung
Alves, Katia
Anez, German
Bennett, Chijioke
Shinde, Vivek
Fries, Louis
Mallory, Raburn M.
Glenn, Gregory M.
Toback, Seth
EXPERT REVIEW OF VACCINES, 2023, 22 (01) : 501 - 517

← 1 2 3 4 5 →